Therapy for Heart Failure w/ Reduced Ejection Fraction - When & How to Introduce SGLT2 Inhibitors

A new class of agents with powerful effects on cardiovascular outcomes has quickly amassed a compelling body of evidence for its use: sodium-glucose cotransporter-2 (SGLT2) inhibitors. Mayo Clinic https://mayocl.in/3tNMAdF Follow Mayo Clinic on Instagram:   / mayoclinic   Like Mayo Clinic on Facebook: https://www.facebook.com/ Follow Mayo Clinic on Twitter:   / mayoclinic